Browsing: Medicare

The Medicare GLP-1 Bridge is a temporary CMS program that gives eligible Medicare Part D beneficiaries access to certain GLP-1 medications for weight management for a $50 monthly copayment. The program runs from July 1, 2026, through December 31, 2027

Some Medicare patients can now receive GLP-1 medication at low cost. The U.S. Centers for Medicare and Medicaid Services started the GLP-1 Bridge Program July 1st to help patients pay for certain weight-loss medicines. Beneficiaries have to meet certain requirements, including a specified body mass index

The arrival of the CMS’sMedicare GLP-1 Bridgeprogram has redrawn the map of drug pricing for weight management, setting a new, predictable monthly price point that is rippling across pharmacies, manufacturers, and care models. Since July 1, 2026, eligible Medicare Part D beneficiaries can access certain GLP-1 medications for a $50 copay through a short-term CMS…